AdvisorShares Investments’s Cardiol Therapeutics CRDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Sell |
857,388
-125,100
| -13% | -$170K | 0.21% | 58 |
|
|
2025
Q1 | $911K | Buy |
982,488
+100,000
| +11% | +$92.8K | 0.18% | 62 |
|
|
2024
Q4 | $1.13M | Sell |
882,488
-288,381
| -25% | -$369K | 0.22% | 47 |
|
|
2024
Q3 | $2.32M | Sell |
1,170,869
-296,103
| -20% | -$586K | 0.44% | 37 |
|
|
2024
Q2 | $2.93M | Buy |
1,466,972
+164,994
| +13% | +$330K | 0.51% | 38 |
|
|
2024
Q1 | $2.36M | Buy |
1,301,978
+112,000
| +9% | +$203K | 0.4% | 37 |
|
|
2023
Q4 | $1,000K | Sell |
1,189,978
-15,810
| -1% | -$13.3K | 0.23% | 46 |
|
|
2023
Q3 | $1.11M | Sell |
1,205,788
-13,950
| -1% | -$12.8K | 0.3% | 39 |
|
|
2023
Q2 | $1.09M | Buy |
1,219,738
+40,000
| +3% | +$35.6K | 0.31% | 37 |
|
|
2023
Q1 | $575K | Buy |
1,179,738
+78,948
| +7% | +$38.5K | 0.18% | 48 |
|
|
2022
Q4 | $733K | Buy |
+1,100,790
| New | +$733K | 0.21% | 84 |
|
|
2021
Q1 | – | Sell |
-348,769
| Closed | -$970K | – | 150 |
|
|
2020
Q4 | $970K | Buy |
348,769
+61,663
| +21% | +$171K | 0.23% | 65 |
|
|
2020
Q3 | $876 | Buy |
287,106
+43,602
| +18% | +$133 | 0.04% | 71 |
|
|
2020
Q2 | $577K | Buy |
243,504
+33,034
| +16% | +$78.3K | 0.25% | 87 |
|
|
2020
Q1 | $600K | Buy |
210,470
+17,790
| +9% | +$50.7K | 0.52% | 44 |
|
|
2019
Q4 | $681K | Buy |
+192,680
| New | +$681K | 0.42% | 94 |
|